FDA Approved: AMINOCAPROIC ACID — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approves Biocon Pharma Inc.'s aminocaproic acid as an original ANDA, authorizing its marketing as an antifibrinolytic to help control or prevent bleeding.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding Disorders
• Hemophilia

Drugs mentioned

• AMINOCAPROIC ACID (aminocaproic acid)

Snippet

ORIG AP for AMINOCAPROIC ACID (AMINOCAPROIC ACID)